Table 2.
Variable | Regression Coefficient for Change in Time-Averaged Albuminuria (95% CI) | P Value for Trend |
---|---|---|
Per increase in log FGF23 (RU/ml) | 0.26 (0.05–0.47) | 0.02 |
Per 10 ml/min/1.73 m2 of eGFR | −0.05 (−0.10 to −0.005) | 0.03 |
Per 0.1 mmol/L of calcium | −0.24 (−0.35 to −0.13) | <0.001 |
Per 1 g/24 hours of albuminuria | 0.45 (0.34–0.57) | <0.001 |
In a stepwise regression model log, fibroblast growth factor-23 (FGF23), age, sex, serum albumin, baseline albuminuria, baseline estimated GFR (eGFR), calcium, phosphate, parathyroid hormone, 25-hydroxyvitamin D, mean arterial BP, body mass index, and use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers were included. Log FGF23, eGFR, calcium, and albuminuria were retained as significant (adjusted R2 = 0.44 for the whole model, P<0.001). The regression coefficients are adjusted for the listed variables. CI, confidence interval; RU, relative units.